Akoya Biosciences, Inc.
AKYA

NASDAQ > Medical - Instruments & Supplies
DCF:$0.03  |   P/E: -
$0.23(8.81%)
Change
Rating:
Price: $2.555 USD
Market Cap: $137.61M

...Loading AKYA Peers...





Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

    330 Employees

    CEO : Mr. Brian McKelligon

    Address : 100 Campus Drive, Marlborough,MA, US, - 01752,

Key ExcutivesDesignation
Ms. Jennifer KamocsayGeneral Counsel
Mr. Brian McKelligonPresident, Chief Executive Officer & Director
Dr. Pascal Bamford Ph.D.Senior Vice President, Research & Development and Laboratory Operations
Dr. Frederic G. Pla Ph.D.Chief Operating Officer
Mr. John Frederick EkChief Financial Officer, Principal Financial Officer & Principal Accounting Officer
Priyam ShahSenior Director of Business Development & Investor Relations Strategy
Dr. Niro Ramachandran Ph.D.Chief Business Officer
Mr. Rob C. Hart CFA, J.D.Secretary